EC Number |
Source Tissue |
Reference |
---|
3.4.21.78 | A-549 cell |
- |
708274 |
3.4.21.78 | acute lymphoblastic leukemia cell line |
acute lymphoblastic leukemia-derived cell line 697 used as a positive control, granzyme A mediated glucocorticoid-induced apoptosis shown |
683723 |
3.4.21.78 | alveolar cell type II |
primary type II pneumocytes and type II pneumocyte, from patients with chronic obstructive pulmonary disease, enriched by Laser capture microdissection (LCM) |
683058 |
3.4.21.78 | alveolar macrophage |
peripheral lung tissue from patients with chronic obstructive pulmonary disease, enriched by Laser capture microdissection (LCM) |
683058 |
3.4.21.78 | B-lymphocyte cell line |
- |
753077 |
3.4.21.78 | blood |
medium expression |
717616 |
3.4.21.78 | bronchoalveolar lavage fluid |
BALF |
-, 752445 |
3.4.21.78 | bronchoalveolar lavage fluid |
BALF, from community-acquired pneumonia (CAP) patients from the Streptococcus pneumoniae serotype 3-infected and contralateral uninfected side and in lung tissue slides from CAP patients and controls. In CAP patients, GzmA levels are increased in BALF obtained from the infected lung, expression analysis, overview |
752445 |
3.4.21.78 | commercial preparation |
- |
717310 |
3.4.21.78 | culture condition:CD8+ cell |
constitutive expression of granzyme A |
-, 752445 |